Reduction of factor XII in antiphospholipid antibody-positive patients with thrombotic events in the rheumatology clinic

Clinical Rheumatology

Volumn 22, Issue 1, 2003, Pages 40-44

  Takeishi, M ^a   Mimori, A ^a   Nakajima, K ^a   Mimura, T ^a   Suzuki, T ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Antiphospholipid antibodies; Factor XII; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 12; CORTICOSTEROID; PHOSPHOLIPID ANTIBODY; PREDNISOLONE; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTERIOSCLEROSIS; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DERMATOMYOSITIS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; OCCLUSIVE CEREBROVASCULAR DISEASE; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THROMBOSIS; VASCULITIS; BLOOD; GENETICS; IMMUNOBLOTTING; IMMUNOLOGY; MIDDLE AGED; PEDIGREE;

ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; FACTOR XII; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; PEDIGREE; RHEUMATIC DISEASES; THROMBOSIS;

EID: 0037866888     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-002-0670-5     Document Type: Article

References (29)

1. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S (1983) Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2: 1211-1214
2. Hughes GRV, Harris EN, Gharavi AE (1986) The anticardiolipin syndrome. J Rheumatol 13: 486-489
3. Asherson RA (1988) A "primary" antiphospholipid syndrome? J Rheumatol 15: 1742-1746
4. Kluft C, Dooijewaard G, Emeis JJ (1987) Role of the contact system in fibrinolysis. Semin Thromb Haemost 13: 50-68
5. Colman RW, Schmaier AH (1997) Contact system: A vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 90: 3819-3843
6. Ratnoff OD, Busse RJ, Shean RP (1968) The demise of John Hageman. N Engl J Med 279: 760-761
7. Mannhalter C, Fischer M, Hopmeier P, Deutsh E (1987) Factor XII activity and antigen concentrations in patients suffering from recurrent thrombosis. Fibrinolysis 1: 259-263
8. Lammle B, Wuillemin WA, Huber I et al. (1991) Thromboembolism and bleeding tendency in congenital factor XII deficiency - a study on 74 subjects from 14 Swiss families. Thromb Haemost 65: 117-121
9. Gris JC, Ripart-Neveu S, Maugard C et al. (1997) Prospective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. Thromb Haemost 77: 1096-1103
10. Sugi T, Makino T (2000) Plasma contact system, kallikrein-kinin system and antiphospholipid-protein antibodies in thrombosis and pregnancy. J Reprod Immunol 47: 169-184
11. Speicher L, Philipp W, Kunz FJ (1992) Factor XII deficiency and central retinal vein occlusion. Lancet 340: 237
12. Abu Ei-Asrar AM, Abdel Gader AGM, Al-Amro S, Al-Momen AK (1998) Hypercoagulable states in patients with retinal venous occlusion. Doc Ophthalmol 95: 133-143
13. Jones DW, Gallimore MJ, Harris SL, Winter M (1999) Antibodies to factor XII associated with lupus anticoagulant. Thromb Haemost 81: 387-390
14. Brey RL, Hart RG, Sherman DG, Tegeler CH (1990) Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 40: 1190-1196
15. Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci L, Inzitari D (1992) Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke 23: 189-193
16. Mueh JR, Herbst KD, Rapaport SI (1980) Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 92: 156-159
17. Elias M, Eldor A (1984) Thromboembolism in patients with the "lupus"-like circulating anticoagulant. Arch Intern Med 144: 510-515
18. Derue GJ, Englert HJ, Harris EN, Gharavi AE, Morgan SH, Hull RG (1985) Fetal loss in systemic lupus: association with anticardiolipin antibodies. J Obstet Gynaecol 5: 207-209
19. Laurell CB (1966) Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15: 45-52
20. Gallimore MJ, Jones DW, Winter M (1998) Factor XII determinations in the presence and absence of phospholipid antibodies. Thromb Haemost 79: 87-90
21. Jones DW, Gallimore MJ, Mackie IJ, Harris SL, Winter M (2000) Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII. Br J Haematol 110: 721-726
22. Halbmayer WM, Haushofer A, Schon A et al. (1994) The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors. Thromb Haemost 71: 68-72
23. Glueck HI, Roehill W (1966) Myocardial infarction in a patient with Hageman (factor XII) defect. Ann Intern Med 64: 390-396
24. Halbmayer WM, Mannhalter C, Feichtinger C, Rubi K, Fischer M (1992) The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolism. Thromb Haemost 68: 285-290
25. Braulke I, Hinney B, Pruggmayer M, Kostering H, Melloh P, Gunther E (1993) Factor XII (Hageman) deficiency in women with habitual abortion: new subpopulation of recurrent aborters? Fertil Steril 59: 98-101
26. Ogasawara M, Aoki K, Katano K, Ozaki Y, Suzumori K (2001) Factor XII but not protein C, protein S, antithrombin III, of factor XIII is a predictor of recurrent miscarriage. Fertil Steril 75: 916-921
27. Levi M, Hack CE, DeBoer JP, Brandjes DPM, Buller HR, Cate JWT (1991) Reduction of the contact activation related fibrinolytic activity in factor XII deficient patients. J Clin Invest 88: 1155-1160
28. Lenich C, Pannell R, Gurewich V (1995) Assembly and activation of the intrinsic fibrinolytic pathway on the surface of human endothelial cells in culture. Thromb Haemost 74: 698-703
29. Braat EAM, Dooijewaard G, Rijken DC (1999) Fibrinolytic properties of activated FXII. Eur J Biochem 263: 904-911